Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report
Respirology Case Reports · 2026-03 · 14 (3)
DOI: 10.1002/rcr2.70529 ↗Kurz gefasst
Fallbericht in der Zeitschrift Respirology Case Reports, online erschienen am 06.03.2026. Verfasst von Riku Watanabe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine Juntendo University Shizuoka Hospital Izunokuni Shizuoka Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A 52‐year‐old man with chronic myeloid leukaemia (CML) who had been receiving dasatinib 100 mg/day for 13 years presented with progressive dyspnea. Chest radiography revealed bilateral pleural effusions, and further evaluation confirmed the diagnosis of chylothorax. Dasatinib‐induced chylothorax was suspected, and discontinuation of the drug led to clinical improvement. Dasatinib is a tyrosine kinase inhibitor (TKI) used for the treatment of CML and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph + ALL). Although pleural effusion is a relatively common adverse effect, chylothorax is an extremely rare complication. This case highlights the importance of considering chylothorax as a potential cause of pleural effusion in patients undergoing long‐term dasatinib therapy. In addition, based on the presumed pathophysiological mechanism, drug discontinuation appears to be the most crucial therapeutic approach for dasatinib‐induced chylothorax.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine Juntendo University Shizuoka Hospital Izunokuni Shizuoka Japan.
- Department of Respiratory Medicine Juntendo University Graduate School of Medicine Tokyo Japan.
ORCID-Profile: Riku Watanabe
Zitieren
APA
Watanabe, R., Iwakami, S. I., Haba, M., Kuroda, Y., Iwakami, N., Fujikawa, E., & Takahashi, K. (2026). Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report. Respirology Case Reports, 14(3). https://doi.org/10.1002/rcr2.70529
Vancouver
Watanabe R, Iwakami SI, Haba M, Kuroda Y, Iwakami N, Fujikawa E, et al. Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report. Respirology Case Reports. 2026;14(3). doi:10.1002/rcr2.70529
BibTeX
@article{Watanabe2026,
author = {Watanabe, Riku and Iwakami, Shin-Ichiro and Haba, Manami and Kuroda, Yumi and Iwakami, Naoko and Fujikawa, Eri and Takahashi, Kazuhisa},
title = {Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report},
journal = {Respirology Case Reports},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/rcr2.70529}
}
EUVIMED